drugset / Trial / NCT02872064
Treatment of Primary Breast Cancer Using PDT
NaSingle-groupOpen-labelTreatment
Summary
Phase I/IIA, open label, non-randomised, single site trial in patients with primary breast cancer.
Timeline
- Start
- 2013-01
- Primary completion
- 2017-11
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Verteporfin | Other / unclassified | 0.4 mg/kg | Intravenous |